Back to Search
JULIE HEIER, PHD, MA
PHD, MA
Psychologist
NPI: 1497231666Individual
Specialties, Licenses & Credentials
Clinical Neuropsychologist
Clinical Neuropsychologist
Code: 103G00000X
Clinical Child & Adolescent Psychologist
Psychologist — Clinical Child & Adolescent
Code: 103TC2200X
Health Psychologist
Psychologist — Health
Code: 103TH0004X
PsychologistPrimary
Psychologist
Code: 103T00000X
Research & Publications (20)
Nanoscale structuring of semiconducting molecular blend films in the presence of mobile counterions.
PMID 18547069·Langmuir·2008
8-other
A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration.
PMID 19643495·Ophthalmology·2009
3-trial
Pathology beyond neovascularization: new targets in age-related macular degeneration.
PMID 19553799·Retina·2009
8-other
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
PMID 19118696·Ophthalmology·2009
3-trial
Implantable telescope for end-stage age-related macular degeneration: long-term visual acuity and safety outcomes.
PMID 18760765·Am J Ophthalmol·2008
2-rct
A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
PMID 18599019·Am J Ophthalmol·2008
4-observational
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.
PMID 17101999·Arch Ophthalmol·2006
3-trial
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
PMID 17021319·N Engl J Med·2006
4-observational
A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema.
PMID 17011952·Ophthalmology·2006
5-case
Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results.
PMID 16989902·Ophthalmology·2006
2-rct
Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.
PMID 16581423·Ophthalmology·2006
3-trial
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.
PMID 16483659·Ophthalmology·2006
3-trial
Visual prosthetic device for bilateral end-stage macular degeneration.
PMID 16293092·Expert Rev Med Devices·2005
8-other
Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study.
PMID 16154198·Ophthalmology·2005
4-observational
Multiple laser treatments for macular edema attributable to branch retinal vein occlusion.
PMID 15808160·Am J Ophthalmol·2005
8-other
Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration.
PMID 15757408·Expert Opin Emerg Drugs·2005
6-review
Innovative treatments for exudative age-related macular degeneration.
PMID 15577563·Int Ophthalmol Clin·2004
6-review
[Surgical indications in intraosseous lipoma of the calcaneus. Case report and critical review of the literature].
PMID 14749853·Unfallchirurg·2004
5-case
Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.
PMID 11054327·Ophthalmology·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- DEPARTMENT OF PSYCHIATRY 100 N ACADEMY AVE
DANVILLE, PA 17822 - Phone
- (570) 271-6516
Quick Facts
- NPI
- 1497231666
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile